Dynasty Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$819K Sell
9,451
-3,621
-28% -$347K 0.01% 193
2025
Q4
$1.26M Buy
13,072
+1,454
+13% +$141K 0.01% 170
2025
Q3
$1.11M Buy
+11,618
New +$1.07M 0.01% 157
2025
Q2
Sell
-3,487
Closed -$313K 241
2025
Q1
$313K Buy
3,487
+656
+23% +$58.7K 0.01% 224
2024
Q4
$226K Buy
+2,831
New +$245K ﹤0.01% 244
2018
Q4
Sell
-3,420
Closed -$336K 61
2018
Q3
$336K Buy
+3,420
New +$316K 0.43% 59

Other funds holding MDT

Dynasty Wealth Management's MDT Position: Q1 2026 in Review

Dynasty Wealth Management reduced its Medtronic (MDT) stake by 28% in Q1 2026, selling an estimated $347K and leaving 9,451 shares worth $819K. The position accounts for 0.01% of the portfolio, ranked #193.

Dynasty Wealth Management first reported a position in MDT in Q3 2018 and has held it in 6 quarters since. The position peaked at $1.26M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Dynasty Wealth Management held 9,451 shares of Medtronic worth $819K as of Q1 2026.
  • Dynasty Wealth Management sold 3,621 Medtronic shares in Q1 2026, an estimated $347K.
  • Medtronic made up 0.01% of Dynasty Wealth Management's portfolio in Q1 2026, its #193 holding.
  • Dynasty Wealth Management first reported a position in Medtronic in Q3 2018 and has held it in 6 quarters since.
  • Dynasty Wealth Management's Medtronic position peaked at $1.26M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Dynasty Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.